Could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?
- PMID: 25614433
- DOI: 10.1016/j.jacc.2014.09.084
Could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?
Comment in
-
Reply: could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?J Am Coll Cardiol. 2015 Jan 27;65(3):312-3. doi: 10.1016/j.jacc.2014.10.039. J Am Coll Cardiol. 2015. PMID: 25614434 No abstract available.
-
Reply: could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?J Am Coll Cardiol. 2015 Jan 27;65(3):313. doi: 10.1016/j.jacc.2014.10.037. J Am Coll Cardiol. 2015. PMID: 25614435 No abstract available.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials